TARSUS PHARMACEUTICALS, INC. Payments of Debt Issuance Costs
TARSUS PHARMACEUTICALS, INC. (TARS) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-02-23
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for the quarter ending 2025-12-31 was $0.00.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for the quarter ending 2024-12-31 was $0.00.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for the quarter ending 2024-09-30 was $39.00K.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for fiscal 2024 was $3.52M.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- TARSUS PHARMACEUTICALS, INC. payments of debt issuance costs for fiscal 2022 was $875.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $39.00K derived: sum of 2 quarters · filed 2026-02-23 | $3.52M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.52M 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | $3.48M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $60.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $60.00K derived: sum of 3 quarters · filed 2025-02-25 | $875.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $60.00K derived: sum of 2 quarters · filed 2023-11-09 | $875.00K 10-Q · filed 2023-11-09 | $875.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $875.00K 10-Q · filed 2023-08-10 | $875.00K derived: sum of 3 quarters · filed 2023-08-10 | $875.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $815.00K 10-Q · filed 2023-05-09 | $815.00K derived: sum of 2 quarters · filed 2023-05-09 | $815.00K derived: sum of 3 quarters · filed 2023-05-09 | $815.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 derived: sum of 3 quarters · filed 2023-03-17 | $0.00 10-K · filed 2023-03-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |